Sinovac Biotech Ltd.
$0
0%
2026-07-22 10:50:01
NMS: SVA
Explore Sinovac Biotech Ltd. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$94.38 M
Current Price
$0
52W High / Low
$6.47 / $6.47
Stock P/E
—
Book Value
$93.27
Dividend Yield
—
ROCE
-4.19%
ROE
-1.44%
Face Value
—
EPS
$-1.25
Exp Qtr EPS
—
Sector
—
SVA — Monthly Price History
Adjusted close price · Hover to see price & month
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Xanadu Quantum Technologies Limited | $10.92 | — | — | — | -45.43% | -1.26% | $57 / $9.75 | — |
| 2. | NVIDIA Corporation | $207.29 | 31.39 | $5,010.37 B | 0.48% | 74.66% | 111.66% | $236.54 / $164.07 | $6.47 |
| 3. | Apple Inc. | $327.74 | 39.17 | $4,800.71 B | 0.33% | 68.72% | 146.69% | $334.99 / $201.5 | $4.99 |
| 4. | Alphabet Inc. | $347.15 | 26.53 | $4,250.75 B | 0.25% | 26.2% | 38.98% | $408.61 / $186.15 | $34.35 |
| 5. | Alphabet Inc. | $346.19 | 26.53 | $4,250.75 B | 0.25% | 26.2% | 38.98% | $408.61 / $186.15 | $34.35 |
| 6. | Microsoft Corporation | $397.75 | 23.71 | $2,968.7 B | 0.92% | 26.9% | 33.13% | $555.45 / $349.2 | $46.2 |
| 7. | Amazon.com, Inc. | $247.55 | 29.37 | $2,667.01 B | — | 13.33% | 23.34% | $278.56 / $196 | $38.31 |
Quarterly Results
Figures shown in M / B
| Sales |
|---|
| Operating Profit |
| Net Profit |
| EPS in Rs |
Profit & Loss
Figures shown in M / B
| 2023 | 2022 | 2021 | |
|---|---|---|---|
| Sales | 448.27 M | 1.49 B | 19.37 B |
| Operating Profit | -524.3 M | -460.85 M | 17.55 B |
| Net Profit | -99.92 M | 113.87 M | 8.47 B |
| EPS in Rs | -1.01 | 1.15 | 85.28 |
Balance Sheet
Figures shown in M / B
| 2023 | 2022 | 2021 | |
|---|---|---|---|
| Total Assets | 13.66 B | 14.11 B | 16.75 B |
| Total Liabilities | 1.64 B | 1.4 B | 2.87 B |
| Equity | 8.71 B | 8.92 B | 9.33 B |
| Current Assets | 11.83 B | 12.13 B | 14.92 B |
| Current Liabilities | 1.15 B | 1.09 B | 2.41 B |
Cash Flow
Last available yearly cash flow history
| 2023 | 2022 | 2021 | |
|---|---|---|---|
| Operating CF | 104 M | -770.75 M | 15.35 B |
| Investing CF | -2.92 B | -5.76 B | -3.02 B |
| Financing CF | -76.06 M | -241.4 M | -1.9 B |
| Free CF | -41.69 M | -1.17 B | 14.63 B |
| Capex | -145.69 M | -403.37 M | -719.98 M |
5Y Margin & Growth History
Last 5 years of annual financial statement data.
| 2023 | 2022 | 2021 | |
|---|---|---|---|
| Revenue Growth % | -69.97% | -92.3% | — |
| Earnings Growth % | -187.75% | -98.66% | — |
| Profit Margin % | -22.29% | 7.63% | 43.7% |
| Operating Margin % | -116.96% | -30.87% | 90.6% |
| Gross Margin % | 59.51% | 54.15% | 94.47% |
| EBITDA Margin % | -1.34% | 12.27% | 91.11% |
Dividend & Split History
Latest dividend payments and stock split events.
Dividend History
| Ex Date | Dividend |
|---|---|
| 2025-07-08 | $55 |
Stock Splits
No stock split history available.